Fingerprint
Dive into the research topics of 'Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib- sensitivetyrosine kinases'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically